Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 97, 148.e17-148.e24
Abstract
No abstract availableKeywords
All Related Versions
This publication has 17 references indexed in Scilit:
- Tracking Parkinson’s: Study Design and Baseline Patient DataJournal of Parkinson’s Disease, 2015
- Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 2015
- Genetic variability in the regulation of gene expression in ten regions of the human brainNature Neuroscience, 2014
- LRRK2 parkinsonism in Tunisia and Norway: A comparative analysis of disease penetranceNeurology, 2014
- Common variation in the LRRK2 gene is a risk factor for Parkinson's diseaseMovement Disorders, 2012
- An anatomically comprehensive atlas of the adult human brain transcriptomeNature, 2012
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyThe Lancet Neurology, 2011
- No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohortNeurobiology of Aging, 2011
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- Whole-Genome Analysis of Sporadic Amyotrophic Lateral SclerosisNew England Journal of Medicine, 2007